Qube Research & Technologies Ltd
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1729829
LONDON, X0
Position in TAK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,385,134
+$32,306,000 QoQ
Shares Held
2,207,432
+1017.6% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#10
of 376 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,279,333 | $163,792,869 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
233,639 | $126,592,619 | |
| 3 | VTRS |
Viatris Inc
|
6,180,223 | $98,141,941 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
922,166 | $42,889,940 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
2,207,432 | $35,385,134 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,893,749 | $22,918,492 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
304,080 | $19,445,916 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
192,945 | $15,971,987 |
All Filings in TAK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,385,134 | 2,207,432 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $3,079,134 | 197,507 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,998,370 | 1,775,845 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,405,759 | 349,661 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,367,304 | 293,699 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,382,379 | 179,938 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,850,263 | 130,117 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $1,586,363 | 114,209 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,186,301 | 433,518 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,435,326 | 286,705 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,494,347 | 731,658 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,552,062 | 336,897 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $3,126,371 | 218,322 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,759,366 | 202,448 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,195,410 | 195,080 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $3,445,899 | 188,713 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,609,260 | 198,311 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,543,558 | 478,899 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,268,324 | 126,510 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||